E Kasafírek
- Topics
- Peptidase Inhibition and Analysis (18 papers)Chemical Synthesis and Analysis (16 papers)Glycosylation and Glycoproteins Research (7 papers)
- Journals
- GutBiochemical JournalFEBS Letters
In The Last Decade
E Kasafírek
60 papers receiving 446 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 195
- Oncology 162
- Cellular and Molecular Neuroscience 98
- Cancer Research 86
- Surgery 51
Countries citing papers authored by E Kasafírek
This map shows the geographic impact of E Kasafírek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Kasafírek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Kasafírek more than expected).
Fields of papers citing papers by E Kasafírek
This network shows the impact of papers produced by E Kasafírek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Kasafírek. The network helps show where E Kasafírek may publish in the future.
Co-authorship network of co-authors of E Kasafírek
This figure shows the co-authorship network connecting the top 25 collaborators of E Kasafírek. A scholar is included among the top collaborators of E Kasafírek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Kasafírek. E Kasafírek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 33 | |
| 5 | Dipeptidyl peptidase IV in the human lung and spinocellular lung cancer. | 16 |
| 6 | 10 | |
| 7 | 20 | |
| 8 | 0 | |
| 9 | 14 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-L-proline-1-naphthylamide and other glycyl-L-proline-arylamides as substrates. | 10 |
| 13 | 8 | |
| 14 | Comparative study of the estimation of exocrine pancreatic function using p-(N-acetyl-L-tyrosyl)- and p-(N-benzoyl-L-tyrosyl)aminobenzoic acid. | 2 |
| 15 | [Endopeptidase isolation in rat enterocyte brush border (author's transl)]. | 1 |
| 16 | 2 | |
| 17 | 14 | |
| 18 | 3 | |
| 19 | 14 | |
| 20 | 26 |
About E Kasafírek
E Kasafírek is a scholar working on Pharmaceutical Science, Oncology and Biotechnology, having authored 65 papers that have together received 474 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (18 papers), Chemical Synthesis and Analysis (16 papers) and Glycosylation and Glycoproteins Research (7 papers). The work is most often cited by research in Oncology (162 citations), Cancer Research (86 citations) and Cellular and Molecular Neuroscience (98 citations). E Kasafírek has collaborated with scholars based in Czechia, Slovakia and India. Frequent co-authors include E Kr̆epela, P Frič, Aleksi Šedo, J. Rudinger, Kerri L. Novak, Karel Jošt, J Kraml, Mikuláš Chavko, J. Kunert and A. L. Zhuze. Their work appears in journals such as Gut, Biochemical Journal and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.